|
Coverage Options For Promising Technologies: Medicare’s ‘Coverage With Evidence Development’
Sean R. Tunis and
Steven D. Pearson
In April 2005 the Centers for Medicare and Medicaid Services (CMS) posted on its Web site a draft guidance document describing a new approach to coverage policy called "coverage with evidence development" (CED). CED offered an option for coverage of promising drugs, biologics, devices, diagnostics, and procedures that would not otherwise meet Medicare’s evidentiary standards for being "reasonable and necessary." An updated guidance was posted 12 July 2006, clarifying several key statutory, regulatory, and operational issues. This paper traces the history of this policy approach, explains the rationale behind the policy, and describes the major challenges that will need to be addressed for CED to become an important advance in evidence-based coverage decision making.
       What's this?
This article has been cited by other articles:
|
|
|
|
 
J. K. Iglehart
Health Insurers and Medical-Imaging Policy -- A Work in Progress
N. Engl. J. Med.,
March 5, 2009;
360(10):
1030 - 1037.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. C. Sox
Evaluating Off-Label Uses of Anticancer Drugs: Time for a Change
Ann Intern Med,
March 3, 2009;
150(5):
353 - 354.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Coye, A. Haselkorn, and S. DeMello
Remote Patient Management: Technology-Enabled Innovation And Evolving Business Models For Chronic Disease Care
Health Aff.,
January 1, 2009;
28(1):
126 - 135.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. E. Hillner, B. A. Siegel, A. F. Shields, D. Liu, I. F. Gareen, E. Hunt, and R. E. Coleman
Relationship Between Cancer Type and Impact of PET and PET/CT on Intended Management: Findings of the National Oncologic PET Registry
J. Nucl. Med.,
December 1, 2008;
49(12):
1928 - 1935.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Khoury, A. Berg, R. Coates, J. Evans, S. M. Teutsch, and L. A. Bradley
The Evidence Dilemma In Genomic Medicine
Health Aff.,
November 1, 2008;
27(6):
1600 - 1611.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Neumann, M. S. Kamae, and J. A. Palmer
Medicare's National Coverage Decisions For Technologies, 1999-2007
Health Aff.,
November 1, 2008;
27(6):
1620 - 1631.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Chalkidou, J. Lord, A. Fischer, and P. Littlejohns
Evidence-Based Decision Making: When Should We Wait For More Information?
Health Aff.,
November 1, 2008;
27(6):
1642 - 1653.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Garber
Is Having More Preapproval Data The Best Way To Assure Drug Safety?
Health Aff.,
September 1, 2008;
27(5):
w371 - w373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Chalkidou, T. Walley, A. Culyer, P. Littlejohns, and A. Hoy
Evidence-informed evidence-making
J Health Serv Res Policy,
July 1, 2008;
13(3):
167 - 173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. F. Anderson and K. Chalkidou
Spending on Medical Care: More Is Better?
JAMA,
May 28, 2008;
299(20):
2444 - 2445.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Douglas, M. Budoff, S. Tunis, P. K. Woodard, R. A. Justman, and R. Honigberg
A New Era for Cardiovascular Imaging? Implications of the Revoked National Coverage Decision for CT Angiography on Future Imaging Reimbursement.
J. Am. Coll. Cardiol. Img.,
May 1, 2008;
1(3):
398 - 403.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. G. Weinmann, Y.-P. Chiang, and S. Sheingold
The National Emphysema Treatment Trial (NETT): A Study in Agency Collaboration
Proceedings of the ATS,
May 1, 2008;
5(4):
381 - 384.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. E. Hillner, B. A. Siegel, D. Liu, A. F. Shields, I. F. Gareen, L. Hanna, S. H. Stine, and R. E. Coleman
Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry
J. Clin. Oncol.,
May 1, 2008;
26(13):
2155 - 2161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Dhruva and R. F. Redberg
Variations Between Clinical Trial Participants and Medicare Beneficiaries in Evidence Used for Medicare National Coverage Decisions
Arch Intern Med,
January 28, 2008;
168(2):
136 - 140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Medicare's Coverage With Evidence Development: A Policy-Making Tool in Evolution
J. Oncol. Pract,
November 1, 2007;
3(6):
296 - 301.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. Foote and R. J. Town
Implementing Evidence-Based Medicine Through Medicare Coverage Decisions
Health Aff.,
November 1, 2007;
26(6):
1634 - 1642.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Chalkidou, A. Hoy, and P. Littlejohns
Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research
J R Soc Med,
October 1, 2007;
100(10):
453 - 460.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Neumann
Challenges Ahead For Federal Technology Assessment
Health Aff.,
March 1, 2007;
26(2):
w150 - w152.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. F. Redberg
Evidence, Appropriateness, And Technology Assessment In Cardiology: A Case Study Of Computed Tomography
Health Aff.,
January 1, 2007;
26(1):
86 - 95.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Keenan, P. J. Neumann, and K. A. Phillips
Biotechnology And Medicare's New Technology Policy: Lessons From Three Case Studies
Health Aff.,
September 1, 2006;
25(5):
1260 - 1269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
